The second time President Donald Trump put the US on the path to quit the Paris Agreement, defenders of the international climate order barely stirred in protest. European Commission President Ursula ...
Media Release Marking Immutep's transition to a Phase III biotech, the Company's pivotal TACTI-004 trial in first-line non-small cell lung cancer (1L NSCLC) received first regulatory approvalMature da ...